Results 241 to 250 of about 6,912,826 (303)

Sarilumab in Polyarticular‐Course Juvenile Idiopathic Arthritis: Dose‐Finding and 1‐Year Analysis of a Phase 2b, Open‐Label, Multicenter Study

open access: yesArthritis Care &Research, EarlyView.
Objective This study assessed sarilumab in treating patients with polyarticular‐course juvenile idiopathic arthritis (pcJIA). Methods This phase 2b, open‐label study (NCT02776735) consisted of three sequential parts (each with a core‐treatment and extension phase).
Fabrizio De Benedetti   +19 more
wiley   +1 more source

Database of <i>CLCN5</i> Pathogenic Variants Causing Dent Disease. [PDF]

open access: yesKidney Int Rep
Lyu P   +7 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy